Glenmark Pharmaceuticals Inc., USA: Alyacen 7/7/7, Norethindrone and Ethinyl Estradiol Tablets USP, 0.5mg/0.035mg, 0.75mg/0.035mg, 1 mg/0.0.35mg, 3 Blister Cards each containin
Read the official notice at FDA (drug) →
Get alerts for Glenmark Pharmaceuticals
The text below is copied from the official FDA (drug) record. If anything differs, the official notice is correct.
- Company / brand
- Glenmark Pharmaceuticals Inc., USA
- Product
- Alyacen 7/7/7, Norethindrone and Ethinyl Estradiol Tablets USP, 0.5mg/0.035mg, 0.75mg/0.035mg, 1 mg/0.0.35mg, 3 Blister Cards each containing 28 tablets, 28 day regimen, Rx only, Manufactured by: Glenmark Pharmaceuticals Ltd., Colvale-Bardez, Goa 403 513, India, Manufactured for: Glenmark Pharmaceuticals Inc., Mahwah, NJ 07430, NDC 68462-556-29
- Reason / hazard
- Failed Impurities/Degradation Specifications: This recall is being initiated due to out-of-specification results total impurities.
- Classification
- Class II
- Status
- Ongoing
- Distribution / sold at
- USA Nationwide.
- Recall initiated
- 2026-05-27
- Code info
- Lot #: 20240411, Exp: 6/30/2026; 20250252, Exp: 3/31/2027
- Voluntary mandated
- Voluntary: Firm initiated
- City
- Elmwood Park
- State
- NJ
- Country
- United States
- Event id
- 99101
Free daily digest + "My products" watchlist